WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013059119) GLUCOSYLCERAMIDE SYNTHASE INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/059119    International Application No.:    PCT/US2012/060244
Publication Date: 25.04.2013 International Filing Date: 15.10.2012
IPC:
C07D 405/06 (2006.01), C07D 207/06 (2006.01), A61K 31/357 (2006.01), A61P 3/00 (2006.01), A61P 25/00 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN [US/US]; Office Of Technology Transfer 1600 Huron Parkway, 2nd Floor Ann Arbor, MI 48109-2590 (US)
Inventors: LARSEN, Scott; (US).
ABE, Akira; (US).
SHU, Liming; (US).
WILSON, Michael, William; (US).
KEEP, Richard, F.; (US).
SHAYMAN, James, A.; (US)
Agent: NAPOLI, James, J.; Marshall, Gerstein & Borun LLP 233 S. Wacker Drive 6300 Willis Tower Chicago, IL 60606-6357 (US)
Priority Data:
61/548,134 17.10.2011 US
Title (EN) GLUCOSYLCERAMIDE SYNTHASE INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
(FR) INHIBITEURS DE LA GLUCOSYLCÉRAMIDE SYNTHASE ET MÉTHODES THÉRAPEUTIQUES À L'AIDE DE CEUX-CI
Abstract: front page image
(EN)Glucosylceramide synthase inhibitore and compositions containing the same are disclosed. Methods of using the glucosylceramide synthase inhibitors in the treatment of diseases and conditions wherein inhibition of glucosylceramide synthase provides a benefit, like Gaucher disease and Fabry disease, also are disclosed.
(FR)L'invention concerne des inhibiteurs de glucosylcéramide synthase et des compositions contenant ceux-ci. L'invention concerne également des procédés d'utilisation des inhibiteurs de la glucosylcéramide synthase dans le traitement de maladies et d'états où l'inhibition de la glucosylcéramide synthase apporte un bénéfice, tels que la maladie de Gaucher et la maladie de Fabry.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)